Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT check in within the app. Participants will also be asked to complete an online survey at the time of enrollment and at 4 and 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedStudy Start
First participant enrolled
June 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
May 6, 2026
December 1, 2025
1.6 years
December 10, 2024
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)
8-measure short form to assess the severity of anxiety symptoms within the Patient-Reported Outcomes Measurement Information System (PROMIS) framework. The total score ranges from 8 to 40, where a higher score indicates greater anxiety.
8 weeks
Secondary Outcomes (4)
Depression as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)
8 weeks
Symptoms of Post-Traumatic Stress Disorder (PTSD) as measured by the PCL-5
8 weeks
Distress as measured by the National Comprehensive Cancer Network's (NCCN) Distress Thermometer (DT)
8 weeks
Ability to deal with stressful situations as measured by the Shift-and-Persist Scale
8 weeks
Study Arms (1)
Interventional arm
EXPERIMENTALStudy participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT (cognitive behavioral therapy) check-in within the app.
Interventions
MM™ includes: 1) CBT; 2) resilience training; 3) mindfulness-based stress reduction; 4) peer support; and 5) family conversations delivered in small virtual groups, with a "mentor" who facilitates resilience-building conversations prompted from "Skill of the Week" lessons.
Eligibility Criteria
You may qualify if:
- years of age
- Prior AYA cancer diagnosis
- Completed primary treatment for their cancer
- Score of 3 or above on the Distress Thermometer at the time of recruitment
You may not qualify if:
- Individuals without legal capacity to give consent
- Individuals who are not fluent in reading, writing, and speaking English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Cancer Institute
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Sophia K Smith, PhD, MSW
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
June 13, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
May 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share